Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide.
暂无分享,去创建一个
B. Martin | G. Kunos | K. Lake | K. Varga | George Kunos | Károly Varga | Billy R. Martin
[1] P. Soubrié,et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor , 1994, FEBS letters.
[2] J. Axelrod,et al. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[3] P. Smith,et al. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. , 1994, The Journal of pharmacology and experimental therapeutics.
[4] S. Munro,et al. Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.
[5] R. Mechoulam,et al. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. , 1993, European journal of pharmacology.
[6] D. Gibson,et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.
[7] J. Paton,et al. Effect of anesthetic on sympathetic responses evoked from cerebellar uvula in decerebrate cats. , 1992, The American journal of physiology.
[8] T. Bonner,et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.
[9] M. Herkenham,et al. Cannabinoid receptor localization in brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[10] C. Iadecola,et al. Lesions of rostral ventrolateral medulla abolish some cardio- and cerebrovascular components of the cerebellar fastigial pressor and depressor responses , 1990, Brain Research.
[11] A. Howlett,et al. Determination and characterization of a cannabinoid receptor in rat brain. , 1988, Molecular pharmacology.
[12] N. Benowitz,et al. Cardiovascular effects of prolonged delta‐9‐tetrahydrocannabinol ingestion , 1975, Clinical pharmacology and therapeutics.
[13] R. Vollmer,et al. Role of the central autonomic nervous system in the hypotension and bradycardia induced by (‐)‐Δ9‐trans‐tetrahydrocannabinol , 1974, The Journal of pharmacy and pharmacology.